Pulmonx Corporation (LUNG) — Financial statements
Income statement, balance sheet, and cash flow for Pulmonx Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 90↑8.0% | 84↑22.0% | 69↑28.0% | 54↑10.8% | 48 | |
| Cost of Revenue | 23↑7.2% | 22↑21.6% | 18↑29.9% | 14↑7.9% | 13 | |
| Gross Profit | 67↑8.3% | 62↑22.2% | 51↑27.3% | 40↑11.9% | 36 | |
| Operating Expenses | ||||||
| R&D Expenses | 19↑10.9% | 18↓2.8% | 18↑17.4% | 15↑17.9% | 13 | |
| General & Administrative Expenses | 0.00↓100.0% | 94↑4.9% | 90 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 8↑64.6% | 5 | 0.00 | 0.00 | |
| SG&A Expenses | 101↓0.8% | 102↑8.0% | 95↑13.8% | 83↑18.9% | 70 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 121↑0.9% | 120↑6.2% | 113↑14.4% | 99↑18.8% | 83 | |
| Total Costs & Expenses | 144↑1.9% | 141↑8.3% | 131↑16.3% | 112↑17.3% | 96 | |
| Operating Results | ||||||
| Operating Income | -54↑7.0% | -58↑6.8% | -62↓5.6% | -59↓24.0% | -47 | |
| Depreciation & Amortization | 1↓33.8% | 2↓18.2% | 2↑28.8% | 2↑74.5% | 0.87 | |
| EBITDA | -53↓3.6% | -51↑7.8% | -55↑1.6% | -56↓20.1% | -47 | |
| EBIT | -54↓2.4% | -52↑8.2% | -57↑0.8% | -58↓21.1% | -47 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.50↓132.4% | 2↓33.5% | 2↑404.5% | 0.46↑207.9% | -0.43 | |
| Interest Income | 3↓47.6% | 5↓9.1% | 6↑264.2% | 2↑282.3% | 0.40 | |
| Interest Expense | 3↓10.0% | 4↑8.5% | 3↑203.2% | 1↑28.6% | 0.83 | |
| Non-Operating Income | 0.00↑100.0% | -5↓8.6% | -5↓332.0% | -1↓712.4% | 0.19 | |
| Other Income / Expenses | 0.29↓84.2% | 2↑8.8% | 2↑2382.1% | 0.07↑106.6% | -1 | |
| Income Before Tax | -53↑4.5% | -56↑7.3% | -60↓2.9% | -59↓21.2% | -48 | |
| Income Tax Expense | 0.63↑25.2% | 0.50↓12.4% | 0.57↑61.8% | 0.35↑2.9% | 0.34 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -54↑4.2% | -56↑7.3% | -61↓3.3% | -59↓21.1% | -49 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -54↑4.2% | -56↑7.3% | -61↓3.3% | -59↓21.1% | -49 | |
| Bottom-Line Net Income | -54↑4.2% | -56↑7.3% | -61↓3.3% | -59↓21.1% | -49 | |
| EPS (Basic) | -1.33↑7.6% | -1.44↑10.0% | -1.60↓0.6% | -1.59↓17.8% | -1.35 | |
| EPS (Diluted) | -1.33↑7.6% | -1.44↑10.0% | -1.60↓0.6% | -1.59↓17.8% | -1.35 | |
| Weighted Average Shares | 41↑4.0% | 39↑3.0% | 38↑2.4% | 37↑2.7% | 36 | |
| Weighted Average Diluted Shares | 41↑4.0% | 39↑3.0% | 38↑2.4% | 37↑2.7% | 36 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.